New CRISPR cancer treatment tested in humans for first time
Researchers have made an important step forward toward a long-desired goal: using the gene-editing technology CRISPR to treat cancer. [Source: Time]
Now, PACT Pharma and UCLA have used CRISPR to remove and add genes to these cells to help them recognize a patient’s specific tumor cells. [...]
By genetically engineering T cells to be better at spotting proteins commonly found on the surfaces of blood cancer cells, researchers have been able to develop treatments — called “CAR-T cell therapies” — for people with those cancers. [..]
Using CRISPR, they knocked out a gene for an existing receptor and inserted a gene for a cancer-targeting receptor into T cells that lacked it. Once they had engineered what they thought would be enough T cells, the researchers infused them back into the patient.
The results: Later biopsies found that up to 20% of the immune cells in the patients’ tumors were the engineered T cells, suggesting that those cells were in fact very adept at homing in on the cancer.
Only two of the 16 participants experienced minor side effects — fever, chills, confusion — attributable to the T cells, but they quickly resolved. [..]
A month after treatment, five of the patients’ tumors were the same size as before, suggesting that the engineered cells may have had a stabilizing effect on their condition.
My thoughts: While the results weren't absolutely mind-staggering, 100% fantastic, the amount that they were able to keep the cancer cells at bay, and normalize the growth is tremendously great.
The researchers went on to say that this may be due to their purposeful limited attack methods, and that this is something they can build on and truly develop a personalized life-saving or extending treatment for cancer.
“We are reprogramming a patient’s immune system to target their own cancer, [..] It’s a living drug, so you can give one dose and ideally have life-long protection [from the cancer].”